Shanghai Yunsheng Medical Laboratory under AccuraGen Holdings participated in the launch of the Inclusive Medical Association, leading the way in cancer gene sequencing technology. . .
On April 15, the American Association for Cancer Research (AACR)2018 annual meeting of the liquid biopsy sub-forum (mini symposium: liquid biopsy 1) gathered lots of experts. . .
The High-throughput Sequencing (NGS) Laboratory of AccuraGen Holdings Group has been accredited by the College of American Pathologists (CAP).
Shanghai Yunsheng Medical Laboratory Co., Ltd., a subsidiary of AccuraGen Holdings, passed the external quality evaluation with 100 marks.
The Precision Medicine World Conference (PMWC) of 2018 was held in Silicon Valley from January 22 to 24 in the United States. At the "liquid biopsy" forum . . .